321 related articles for article (PubMed ID: 23409972)
1. Design, synthesis, and biological evaluations of novel 7-[7-amino-7-methyl-5-azaspiro[2.4]heptan-5-yl]-8-methoxyquinolines with potent antibacterial activity against respiratory pathogens.
Odagiri T; Inagaki H; Sugimoto Y; Nagamochi M; Miyauchi RN; Kuroyanagi J; Kitamura T; Komoriya S; Takahashi H
J Med Chem; 2013 Mar; 56(5):1974-83. PubMed ID: 23409972
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, antibacterial activity, and toxicity of 7-(isoindolin-5-yl)-4-oxoquinoline-3-carboxylic acids. Discovery of the novel des-F(6)-quinolone antibacterial agent garenoxacin (T-3811 or BMS-284756).
Hayashi K; Takahata M; Kawamura Y; Todo Y
Arzneimittelforschung; 2002; 52(12):903-13. PubMed ID: 12572531
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Biological Evaluation of Novel 7-[(3 aS,7 aS)-3 a-Aminohexahydropyrano[3,4- c]pyrrol-2(3 H)-yl]-8-methoxyquinolines with Potent Antibacterial Activity against Respiratory Pathogens.
Odagiri T; Inagaki H; Nagamochi M; Kitamura T; Komoriya S; Takahashi H
J Med Chem; 2018 Aug; 61(16):7234-7244. PubMed ID: 30063826
[TBL] [Abstract][Full Text] [Related]
4. (Fluorocyclopropyl)quinolones. 2. Synthesis and Stereochemical structure-activity relationships of chiral 7-(7-amino-5-azaspiro[2.4]heptan-5-yl)-1-(2-fluorocyclopropyl)quinolone antibacterial agents.
Kimura Y; Atarashi S; Kawakami K; Sato K; Hayakawa I
J Med Chem; 1994 Sep; 37(20):3344-52. PubMed ID: 7932562
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of 5-amino-6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-8-methylquinolonecarboxylic acid antibacterials having fluorinated 7-[(3R)-3-(1-aminocyclopropan-1-yl)pyrrolidin-1-yl] substituents.
Inagaki H; Miyauchi S; Miyauchi RN; Kawato HC; Ohki H; Matsuhashi N; Kawakami K; Takahashi H; Takemura M
J Med Chem; 2003 Mar; 46(6):1005-15. PubMed ID: 12620077
[TBL] [Abstract][Full Text] [Related]
6. [In vitro comparative activity of moxifloxacin and other antimicrobials against respiratory pathogens].
Prado V; Giangrieco M; Durán C; Ojeda A; van Flaskamp R
Rev Med Chil; 2000 Dec; 128(12):1319-26. PubMed ID: 11227240
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antibacterial activity of novel 4''-carbamates of 6,11-di-O-methylerythromycin A.
Wu Z; Lu Y; Luo M; He X; Xiao Y; Yang J; Pan Y; Qiu G; Xu Y; Huang W; Long P; Li R; Hu X
J Antibiot (Tokyo); 2010 Jul; 63(7):343-50. PubMed ID: 20448668
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
Jacobs E; Dalhoff A; Korfmann G
Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
[TBL] [Abstract][Full Text] [Related]
9. The synthesis and biological evaluation of a novel series of C7 non-basic substituted fluoroquinolones as antibacterial agents.
Huang X; Chen D; Wu N; Zhang A; Jia Z; Li X
Bioorg Med Chem Lett; 2009 Aug; 19(15):4130-3. PubMed ID: 19539467
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and SAR study of novel 7-(pyridinium-3-yl)-carbonyl imidazo[5,1-b]thiazol-2-yl carbapenems.
Maruyama T; Kano Y; Yamamoto Y; Kurazono M; Iwamatsu K; Atsumi K; Shitara E
Bioorg Med Chem; 2007 Jan; 15(1):392-402. PubMed ID: 17055731
[TBL] [Abstract][Full Text] [Related]
11. [In vitro activity of trovafloxacin in 238 respiratory pathogens].
Alarcón T; Domingo D; Prieto N; Sánchez S; López-Brea M
Rev Esp Quimioter; 1998 Mar; 11(1):47-51. PubMed ID: 9795289
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluations of novel 7-[3-(1-aminocycloalkyl)pyrrolidin-1-yl]-6-desfluoro-8-methoxyquinolones with potent antibacterial activity against multi-drug resistant Gram-positive bacteria.
Miyauchi R; Kawakami K; Ito M; Matsuhashi N; Ohki H; Inagaki H; Takahashi H; Takemura M
Bioorg Med Chem; 2009 Oct; 17(19):6879-89. PubMed ID: 19736016
[TBL] [Abstract][Full Text] [Related]
13. Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values.
Jones RN; Fritsche TR; Sader HS; Stilwell MG
Diagn Microbiol Infect Dis; 2007 May; 58(1):9-17. PubMed ID: 17408903
[TBL] [Abstract][Full Text] [Related]
14. [Synthesis and antibacterial activity of 7-(7-aminomethyl-5-azaspiro [2,4] hept-5-yl)-1-cyclopropyl-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid and its analogues].
Qi JJ; Guo HY; Liu ML; Sun LY
Yao Xue Xue Bao; 2004 Mar; 39(3):184-9. PubMed ID: 15171652
[TBL] [Abstract][Full Text] [Related]
15. A novel antibacterial 8-chloroquinolone with a distorted orientation of the N1-(5-amino-2,4-difluorophenyl) group.
Kuramoto Y; Ohshita Y; Yoshida J; Yazaki A; Shiro M; Koike T
J Med Chem; 2003 May; 46(10):1905-17. PubMed ID: 12723953
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-5-amino/methylaminopiperidin-1-yl)fluoroquinolone derivatives.
Zhang Y; Li G; Liu M; You X; Feng L; Lv K; Cao J; Guo H
Bioorg Med Chem Lett; 2011 Feb; 21(3):928-31. PubMed ID: 21232952
[TBL] [Abstract][Full Text] [Related]
17. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010].
Wang H; Liu YL; Chen MJ; Xu YC; Sun HL; Yang QW; Hu YJ; Cao B; Chu YZ; Liu Y; Zhang R; Yu YS; Sun ZY; Zhuo C; Ni YX; Hu BJ
Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):113-9. PubMed ID: 22455967
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin derivatives): a new class of antibacterials highly potent against macrolide-resistant and -susceptible respiratory pathogens.
Agouridas C; Denis A; Auger JM; Benedetti Y; Bonnefoy A; Bretin F; Chantot JF; Dussarat A; Fromentin C; D'Ambrières SG; Lachaud S; Laurin P; Le Martret O; Loyau V; Tessot N
J Med Chem; 1998 Oct; 41(21):4080-100. PubMed ID: 9767644
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antibacterial activity of 7-(1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-7-yl) quinolones.
Zhu B; Marinelli BA; Goldschmidt R; Foleno BD; Hilliard JJ; Bush K; Macielag MJ
Bioorg Med Chem Lett; 2009 Sep; 19(17):4933-6. PubMed ID: 19646867
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in-vitro antibacterial activity of 7-(3-aminopyrrolo[3,4-c]pyrazol-5(2H,4H,6H)-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivatives.
Guo X; Bai XG; Li YL; An ZJ; Xu LX; Han LY; Liu ML; Guo HY; Wang YC
Arch Pharm (Weinheim); 2011 Aug; 344(8):523-9. PubMed ID: 21656543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
